Phase I/II trial of oral hydroxyurea in combination with pegylated interferon and ribavirin in chronic hepatitis C patients
Phase 1
- Conditions
- Chronic hepatitis C
- Registration Number
- JPRN-UMIN000003457
- Lead Sponsor
- Yokohama City University Medical Center Gastroenterological Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1)Pregnant or lactating Women 2)Patients with uncontrolled heart disease 3)Patients with uncontorolled DM or HT 4)Patients with inadequate haematological status 5) Patients with exclusion criteria for PEG/RBV therapy 6) Patient with decision of exclusion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PhaseI:The safety PhseII:Antiviral effect
- Secondary Outcome Measures
Name Time Method PhaseI:Antiviral effect PhaseII: The safety, ALT change